Medical Device PLI Scheme: Big Overhaul Through 2036
The Department of Pharmaceuticals has announced an ambitious overhaul of the medical device PLI scheme. Consequently, the government has extended the program until financial year 2035–2036. This strategic initiative deploys an unutilized outlay of approximately ₹2,700 crore. Moreover, policymakers have redesigned the eligibility framework to lower financial barriers for domestic MedTech manufacturers.
Key Changes in the Medical Device PLI Scheme
Under the revised guidelines, officials have eliminated the minimum sales threshold to claim financial incentives. Furthermore, the authorities significantly reduced the initial capital investment requirement from ₹180 crore. As a result, smaller enterprises and innovative startups can participate more easily. In addition, manufacturers now receive three full years to build operational infrastructure across target segments. Therefore, companies face fewer operational bottlenecks during setup.
Target Segments and Component Focus
The revamped scheme classifies manufacturing activities into four core target categories. Specifically, the segments encompass consumables, critical components, nascent high-tech devices, and imported assembled equipment. In the critical components and nascent equipment segments, companies can access incentives averaging nine percent. Meanwhile, consumables and disposables receive an average incentive rate of five percent. Consequently, India aims to build self-reliance for critical parts that form the backbone of modern diagnostics.
Clinical Impact on Indian Healthcare
Since its inception, the program has driven domestic production worth over ₹16,000 crore. For instance, Indian facilities now manufacture CT scanners, linear accelerators, mammography units, and specialized implants locally. However, advanced systems like 3T MRI units, PET-CT scanners, and high-throughput diagnostic analyzers still rely heavily on imports. Thus, expanding domestic manufacturing will reduce procurement costs for healthcare institutions. Ultimately, improved local access helps hospitals deliver more affordable care to patients nationwide.
Frequently Asked Questions
Q1: What is the main objective of the extended PLI scheme?
The program aims to promote deep domestic manufacturing of critical components, consumables, and high-end diagnostic equipment like 3T MRI and PET-CT scanners.
Q2: How do the revised guidelines support smaller manufacturers?
The government removed the minimum sales threshold and reduced minimum capital investment rules, allowing wider industry participation.
Q3: When will the online application portal open?
The Department of Pharmaceuticals indicated that the official application portal will become operational within ten days.
References
- Centre extends medical device PLI Scheme to 2036, eases entry barriers - ETHealthworld
- Fresh applications invited under PLI Scheme for Medical Devices - Press Information Bureau
- Medical device PLI scheme extended by 8 years; focus shifts to components - Business Standard
